1659: Effects of Finasteride and Saw Palmetto on BPSA, Propsa, and cPSA in Men with Benign Prostatic Hyperplasia

2004 ◽  
Vol 171 (4S) ◽  
pp. 438-439
Author(s):  
Lori J. Sokoll ◽  
Leonard S. Marks ◽  
Stephen D. Mikolajczyk ◽  
Debra J. Bruzek ◽  
Phaedre Mohr ◽  
...  
2004 ◽  
Vol 32 (03) ◽  
pp. 331-338 ◽  
Author(s):  
Edward M. Gong ◽  
Glenn S. Gerber

Benign prostatic hyperplasia (BPH) is a common health issue that affects 8% of all men at the age of 40, 60% of men in their 70s, and 90% of those greater than 80 years of age. One-fourth of these men will develop moderate to severe lower urinary tract symptoms that greatly affect their quality of life. Recent evidence suggests that the use of saw palmetto leads to improvements in urinary function for those suffering from BPH. The favorable comparison of saw palmetto with tamsulosin, a well-known first line agent in the treatment of urinary tract symptoms, demonstrates promise towards a beneficial effect of this herbal agent, with very few, if any, adverse effects. However, what degree of this beneficial activity is due to placebo effects is yet to be determined. In addition, the precise mechanism of action of saw palmetto in men with BPH remains unclear.


2006 ◽  
Vol 354 (6) ◽  
pp. 557-566 ◽  
Author(s):  
Stephen Bent ◽  
Christopher Kane ◽  
Katsuto Shinohara ◽  
John Neuhaus ◽  
Esther S. Hudes ◽  
...  

2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Heeok Hong ◽  
Chun‐Soo Kim ◽  
Jung Sug Lee ◽  
Won Jai Maeng

Sign in / Sign up

Export Citation Format

Share Document